Spermidine In Alzheimer’S Disease: Evidence From Animal Models And Human Studies
A natural compound called spermidine is gaining attention for its potential role in brain health, particularly in the context of age-related cognitive decline. This compound is a type of polyamine, which are molecules essential for various cellular processes, including cell growth and the creation of new proteins. One of its most significant actions is activating “autophagy,” a vital cellular cleanup process where cells remove damaged components and recycle them. This cellular housekeeping is crucial because, in conditions like Alzheimer’s disease, abnormal proteins and cellular waste can accumulate in the brain, leading to dysfunction.
Beyond its role in cellular cleanup, spermidine also appears to have other beneficial effects. It acts as an anti-inflammatory agent, reducing harmful inflammation in the brain, and possesses antioxidant properties, which help protect cells from damage. It also supports the healthy functioning of mitochondria, the powerhouses of our cells. Studies in animal models of aging and Alzheimer’s have consistently shown that administering spermidine can lead to improvements in memory and overall brain function.
While the findings from animal studies are encouraging, research in humans is still in its early stages. Some observational studies suggest a link between higher dietary intake of spermidine and better cognitive abilities, but these studies don’t prove that spermidine directly causes these improvements. Clinical trials investigating spermidine supplementation in people have been few, often small, and have yielded mixed results. Therefore, while spermidine presents a biologically plausible way to influence pathways relevant to neurodegeneration, more extensive and well-designed human studies are needed to confirm its effectiveness and determine its potential as a therapeutic or preventive measure for Alzheimer’s disease.
Source: link to paper